Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Anecortave (Alcon Laboratories).

Vinores SA.

IDrugs. 2005 Apr;8(4):327-34. Review.

PMID:
15800808
2.

Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.

Russell SR, Hudson HL, Jerdan JA; Anecortave Acetate Clinical Study Group.

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S79-90. Review.

PMID:
17240260
3.

Anecortave acetate.

Bakri SJ, Kaiser PK.

Expert Opin Investig Drugs. 2006 Feb;15(2):163-9. Review. Erratum in: Expert Opin Investig Drugs. 2006 May;15(5):573.

PMID:
16433595
5.

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.

D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger DS, Luna SP, Robertson SM, Russell S, Singerman L, Slakter JS, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group.

Ophthalmology. 2003 Dec;110(12):2372-83; discussin 2384-5.

PMID:
14644721
6.

Preclinical efficacy of anecortave acetate.

Clark AF.

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S41-8. Review.

PMID:
17240256
7.

Pharmacokinetics and metabolism of anecortave acetate in animals and humans.

Dahlin DC, Rahimy MH.

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S49-61. Review.

PMID:
17240257
8.

Anecortave acetate for fibrotic lesions with presence of residual peripheral activity in age-related macular degeneration.

Aggermann T, Haas P, Binder S.

Ann Ophthalmol (Skokie). 2008 Spring;40(1):28-30.

PMID:
18556978
9.

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group.

Retina. 2003 Feb;23(1):14-23.

PMID:
12652226
10.

Posterior juxtascleral depot administration of anecortave acetate.

Kaiser PK, Goldberg MF, Davis AA; Anecortave Acetate Clinical Study Group.

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S62-9. Review.

PMID:
17240258
11.

[Present status of studies on the treatment of choroidal neovascularization by Anecortave acetate].

Li X, Wang YS.

Zhonghua Yan Ke Za Zhi. 2008 Jun;44(6):571-4. Review. Chinese.

PMID:
19035252
12.

American Society of Clinical Oncology--41st annual meeting. Drug highlights I.

Shah S, Yager N.

IDrugs. 2005 Jul;8(7):531-3. No abstract available.

PMID:
15973555
13.

Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.

Klais CM, Eandi CM, Ober MD, Sorenson JA, Sadeghi SN, Freund KB, Spaide RF, Slakter JS, Yannuzzi LA.

Retina. 2006 Sep;26(7):773-9.

PMID:
16963850
14.

Mechanism of action of the angiostatic cortisene anecortave acetate.

Clark AF.

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S26-34. Review.

PMID:
17240253
15.

The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

Penn JS, Rajaratnam VS, Collier RJ, Clark AF.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):283-90.

PMID:
11133880
16.

Anecortave acetate in the treatment of age-related macular degeneration.

Augustin A.

Clin Interv Aging. 2006;1(3):237-46. Review.

17.

Anecortave acetate.

Clarke MS.

Ophthalmology. 2004 Dec;111(12):2316; author reply 2316-7. No abstract available.

PMID:
15582099
18.

Preclinical safety of anecortave acetate.

Heaton J, Kastner P, Hackett R.

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S35-40. Review.

PMID:
17240255
19.

First clinical experience with anecortave acetate (Retaane).

Hayek S, Scherrer M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Menghini M, Helbig H, Sutter FK.

Klin Monbl Augenheilkd. 2007 Apr;224(4):279-81.

PMID:
17458792
20.

Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation.

Robin AL, Clark AF, Covert DW, Krueger S, Bergamini MV, Landry TA, Dickerson JE Jr, Scheib SA, Realini T, Defaller JM, Cagle GD.

Am J Ophthalmol. 2009 Jan;147(1):45-50.e2. doi: 10.1016/j.ajo.2008.07.039. Epub 2008 Sep 13.

PMID:
18789793

Supplemental Content

Support Center